Emerging therapies for melanoma.
Substantial progress has been made in understanding the pathogenesis of malignant melanoma at the cellular level, leading to the development of several new agents in the treatment of melanoma. The focus of this review is to summarize the emerging therapies and investigational agents in the treatment of melanoma over the last 5 years.
Katipamula
Rajini
R
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. katipamula.rajini@mayo.edu
Markovic
Svetomir N
SN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D019264:Adoptive Transfer; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D007167:Immunotherapy; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D047428:Protein Kinase Inhibitors